Null Results in Brief
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench; on behalf of the Australian Ovarian Cancer Study, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich
Lara E. Sucheston-Campbell
College of Pharmacy, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio.
Rikki Cannioto
Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Alyssa I. Clay
Cancer Genetic Epidemiology, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
John Lewis Etter
Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Kevin H. Eng
Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
Song Liu
Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
Sebastiano Battaglia
Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York.
Qiang Hu
Department of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York.
J. Brian Szender
Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
Albina Minlikeeva
Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Janine M. Joseph
Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Paul Mayor
Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
Scott I. Abrams
Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.
Brahm H. Segal
Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York.Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
Paul K. Wallace
Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York.
Kah Teong Soh
Department of Flow & Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York.
Emese Zsiros
Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
Hoda Anton-Culver
Genetic Epidemiology Research Institute, School of Medicine, University of California Irvine, Irvine, California.
Elisa V. Bandera
Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Matthias W. Beckmann
Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Andrew Berchuck
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
Line Bjorge
Department of Gynecology and Obstetrics, Haukeland University Horpital, Bergen, Norway.Department of Clinical Science, Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
Amanda Bruegl
Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
Ian G. Campbell
Cancer Genetics Laboratory, East Melbourne, Australia.Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
Shawn Patrice Campbell
Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
Georgia Chenevix-Trench
Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
Daniel W. Cramer
Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Agnieszka Dansonka-Mieszkowska
Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Fanny Dao
Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
Brenda Diergaarde
Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
Thilo Doerk
Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
Jennifer A. Doherty
Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Andreas du Bois
Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Diana Eccles
Faculty of Medicine, University of Southampton, Southampton, United Kingdom.Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Southampton, United Kingdom.
Svend Aage Engelholm
Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Peter A. Fasching
Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Simon A. Gayther
Center for Cancer Prevention and Translational Genomics, Cedars-Sinai Medical Center, Los Angeles, California.Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
Aleksandra Gentry-Maharaj
Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Rosalind M. Glasspool
The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Marc T. Goodman
Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.Department of Biomedical Sciences, Community and Population Health Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Jacek Gronwald
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Philipp Harter
Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
Alexander Hein
Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Florian Heitz
Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Peter Hillemmanns
Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
Claus Høgdall
Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark.
Estrid V.S. Høgdall
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
Tomasz Huzarski
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Allan Jensen
Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Sharon E. Johnatty
Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
Audrey Jung
Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany.
Beth Y. Karlan
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Reudiger Klapdor
Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany.
Tomasz Kluz
Clinic of Obstetrics and Gynecology, Institute of Midwifery and Emergency Medicine, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland.
Bożena Konopka
Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Susanne Krüger Kjær
Department of Gynaecology, Rigshospitalet, University of Copenhagen, Herlev, Denmark.Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Jolanta Kupryjanczyk
Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Diether Lambrechts
Department of Oncology, Laboratory for Translational Genetics, Vesalius Research Center, University of Leuven, Leuven, Belgium.
Jenny Lester
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Jan Lubiński
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
Douglas A. Levine
Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
Lene Lundvall
Department of Gynecology, The Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Valerie McGuire
Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
Iain A. McNeish
Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, United Kingdom.
Usha Menon
Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Francesmary Modugno
Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
Roberta B. Ness
The University of Texas School of Public Health, Houston, Texas.
Sandra Orsulic
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
James Paul
The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Celeste Leigh Pearce
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Tanja Pejovic
Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
Paul Pharoah
Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Susan J. Ramus
School of Women's and Children's Health, University of New South Wales, New South Wales, Australia.The Kinghorn Cancer Centre, Garvan Institute of Medical Research, New South Wales, New South Wales, Australia.
Joseph Rothstein
Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
Mary Anne Rossing
Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.Department of Epidemiology, University of Washington, Seattle, Washington.
Matthias Rübner
Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Joellen M. Schildkraut
Department of Public Health Sciences, The University of Virginia, Charlottesville, Virginia.
Barbara Schmalfeldt
Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ira Schwaab
Praxis für Humangenetik, Wiesbaden, Germany.
Nadeem Siddiqui
Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom.
Weiva Sieh
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Piotr Sobiczewski
Department of Gynecologic Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Honglin Song
Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Kathryn L. Terry
Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts.Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Els Van Nieuwenhuysen
Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Adriaan Vanderstichele
Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Ignace Vergote
Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Christine S. Walsh
Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Penelope M. Webb
Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Australia.
Nicolas Wentzensen
Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
Alice S. Whittemore
Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California.
Anna H. Wu
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Argyrios Ziogas
Department of Epidemiology, University of California Irvine, Irvine, California.
Kunle Odunsi
Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
Jenny Chang-Claude
Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Heidelberg, Germany.
Ellen L. Goode
Department of Health Science Research, Mayo Clinic, Rochester, Minnesota.
Kirsten B. Moysich
Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
DOI: 10.1158/1055-9965.EPI-16-0631 Published March 2017
Article Figures & Data
Figures
- Figure 1.
These five concentric circles are circular standard Manhattan plots. The chromosome is on the outer circle, −log10 P values are on the y-axis (vertical), with each circle representing the P value from single SNP tests of association with overall survival adjusted for age, stage, and grade. A–E, The Manhattan plots are as follows: all ovarian cancer cases (A); high-grade serous (B); mucinous cell (C); endometrioid (D); and clear cell (E). The red dashed line designates P = 0.01, −log10(P value) = 2, with all red-colored SNPs above that line reflecting SNPs P < 0.01.
Tables
- Table 1.
Clinical characteristics of invasive EOC cases from the Ovarian Cancer Association Consortium analyzed for association with MSDC genetic variation
Vital status at last follow-up Patient characteristics Alive Deceased Total invasive EOC cases n = 5,243 (48.8%) n = 5,508 (51.2%) N = 10,751 Age at diagnosis <50 years 1,627 (59.1%) 1,125 (40.9%) 2,752 50–69 years 3,100 (47.4%) 3,445 (52.6%) 6,545 70+ years 516 (35.5%) 938 (64.5%) 1,454 Histology Serous 2,765 (39.7%) 4,207 (60.3%) 6,972 High-grade serous 2,210 (38.2%) 3,568 (61.8%) 5,578 Mucinous 504 (72.1%) 197 (27.9%) 701 Endometrioid 1,058 (68.7%) 485 (31.3%) 1,543 Clear cell 529 (67.1%) 260 (32.9%) 789 Mixed cell 215 (56.7%) 166 (43.3%) 381 Undifferentiated/poorly differentiated 92 (42.6%) 124 (57.4%) 216 Unknown epithelial 70 (49.6%) 69 (50.3%) 139 Grade Well differentiated 757 (70.5%) 316 (29.3%) 1,073 Moderately differentiated 1,107 (50.6%) 1,079 (49.4%) 2,186 Poorly differentiated 2,185 (42.4%) 2,969 (57.6%) 5,154 Undifferentiated 284 (46.8%) 323 (53.2%) 607 Unknown 583 (58.1%) 419 (41.9%) 1,002 Stage Localized 1,393 (81.3%) 320 (18.7%) 1,713 Regional 1,314 (66.4%) 665 (33.6%) 1,979 Distant 2,109 (34.3%) 4,034 (65.7%) 6,134 Unknown 178 (55.5%) 143 (44.5%) 321
March 2017
Volume 26, Issue 3
Volume 26, Issue 3
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich on behalf of the Australian Ovarian Cancer Study
Cancer Epidemiol Biomarkers Prev March 1 2017 (26) (3) 420-424; DOI: 10.1158/1055-9965.EPI-16-0631
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Lara E. Sucheston-Campbell, Rikki Cannioto, Alyssa I. Clay, John Lewis Etter, Kevin H. Eng, Song Liu, Sebastiano Battaglia, Qiang Hu, J. Brian Szender, Albina Minlikeeva, Janine M. Joseph, Paul Mayor, Scott I. Abrams, Brahm H. Segal, Paul K. Wallace, Kah Teong Soh, Emese Zsiros, Hoda Anton-Culver, Elisa V. Bandera, Matthias W. Beckmann, Andrew Berchuck, Line Bjorge, Amanda Bruegl, Ian G. Campbell, Shawn Patrice Campbell, Georgia Chenevix-Trench, Daniel W. Cramer, Agnieszka Dansonka-Mieszkowska, Fanny Dao, Brenda Diergaarde, Thilo Doerk, Jennifer A. Doherty, Andreas du Bois, Diana Eccles, Svend Aage Engelholm, Peter A. Fasching, Simon A. Gayther, Aleksandra Gentry-Maharaj, Rosalind M. Glasspool, Marc T. Goodman, Jacek Gronwald, Philipp Harter, Alexander Hein, Florian Heitz, Peter Hillemmanns, Claus Høgdall, Estrid V.S. Høgdall, Tomasz Huzarski, Allan Jensen, Sharon E. Johnatty, Audrey Jung, Beth Y. Karlan, Reudiger Klapdor, Tomasz Kluz, Bożena Konopka, Susanne Krüger Kjær, Jolanta Kupryjanczyk, Diether Lambrechts, Jenny Lester, Jan Lubiński, Douglas A. Levine, Lene Lundvall, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Roberta B. Ness, Sandra Orsulic, James Paul, Celeste Leigh Pearce, Tanja Pejovic, Paul Pharoah, Susan J. Ramus, Joseph Rothstein, Mary Anne Rossing, Matthias Rübner, Joellen M. Schildkraut, Barbara Schmalfeldt, Ira Schwaab, Nadeem Siddiqui, Weiva Sieh, Piotr Sobiczewski, Honglin Song, Kathryn L. Terry, Els Van Nieuwenhuysen, Adriaan Vanderstichele, Ignace Vergote, Christine S. Walsh, Penelope M. Webb, Nicolas Wentzensen, Alice S. Whittemore, Anna H. Wu, Argyrios Ziogas, Kunle Odunsi, Jenny Chang-Claude, Ellen L. Goode and Kirsten B. Moysich on behalf of the Australian Ovarian Cancer Study
Cancer Epidemiol Biomarkers Prev March 1 2017 (26) (3) 420-424; DOI: 10.1158/1055-9965.EPI-16-0631
Jump to section
Advertisement